Divi’s Laboratories shares get an upgrade from HSBC who raises price target by 57%

Of the 31 analysts that have coverage on the stock, 14 have a “buy” rating, seven have a “hold” rating and 10 have a “sell” rating.

Leave a Reply

Your email address will not be published. Required fields are marked *